Could higher interest rates in the US boost growth?

Economists have started to wonder if keeping interest rates low in the US is doing more harm than good.

Last week's meeting of America's Federal Open Market Committee, the interest-rate-setting group at the Federal Reserve, attracted less attention than usual due to the drama over Greece. Not that anything much happened: Fed chair Janet Yellen said the labour market had strengthened a bit, but that the Fed would need to see evidence that the recovery was gathering pace before raising rates for the first time in nine years.

In short, we got more excuses for keeping interest rates at zero when the economy is not in crisis, says Michael Lewitt on moneymorning.com. The upshot is that most are pencilling in a September hike, but they could well be disappointed. "Whatever courage the Fed demonstrated during the financial crisis has long... given way to cowardice and fear that it might upset the market by doing its job."

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up
Andrew Van Sickle
Editor, MoneyWeek

Andrew is the editor of MoneyWeek magazine. He grew up in Vienna and studied at the University of St Andrews, where he gained a first-class MA in geography & international relations.

After graduating he began to contribute to the foreign page of The Week and soon afterwards joined MoneyWeek at its inception in October 2000. He helped Merryn Somerset Webb establish it as Britain’s best-selling financial magazine, contributing to every section of the publication and specialising in macroeconomics and stockmarkets, before going part-time.

His freelance projects have included a 2009 relaunch of The Pharma Letter, where he covered corporate news and political developments in the German pharmaceuticals market for two years, and a multiyear stint as deputy editor of the Barclays account at Redwood, a marketing agency.

Andrew has been editing MoneyWeek since 2018, and continues to specialise in investment and news in German-speaking countries owing to his fluent command of the language.